Seeking Alpha

Rosetta Stone (RST +19.1%) is doing the exact opposite of what it did 3 months ago, taking off...

Rosetta Stone (RST +19.1%) is doing the exact opposite of what it did 3 months ago, taking off after beating Q3 estimates and raising its 2012 adjusted EBITDA guidance to $8M-$10M from a prior $6M-$8M. International consumer and institutional sales respectively fell 8% and 6% Y/Y in Q3, but U.S. consumer rose 5%, and bookings growth of 9% exceeded flat revenue growth. Rosetta noted on its earnings call that its direct-to-consumer sales efforts in the U.S. are lifting bookings.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs